European Archives - Page 198 of 1301 - European Medical Journal

Silicon-Covered Metallic Mesh Stents for Malignant Ureteral Obstruction

To evaluate the efficacy and safety of silicone-covered metallic ureteral stents (MUS) compared with double-J (D-J) stents in patients…

Hidden heroes of healthcare: Reaching NPs and PAs

Nurse practitioners and physician assistants are vital players in US healthcare, yet the industry often overlooks them.

Smart Bandage Detects Early Infections and Predicts Healing Times

A smart bandage detects infections days early, predicts healing via biomarkers and AI, and has been tested successfully in human patients.

ESWL versus FURS: Findings from PUrE RCT 1

New data from PUrE RCT 1 reveals no difference in quality-of-life between patients treated with ESWL or FURS for ≤10 mm LPSs.

Janice Walshe

Onc Now: Episode 16: Fertility, Funding, and the Future of Oncology

Janice Walshe, Consultant Medical Oncologist at St Vincent’s University Hospital in Dublin, explores access to innovation in cancer care, the challenges of fertility preservation, and the future of oncology in Ireland.

Accelerated MRI Shows High Diagnostic Accuracy for Knee Injuries

AI-accelerated knee MRI delivers sub–5-minute scans with high diagnostic accuracy, validated against arthroscopic surgical findings.

Nipple-Sparing Mastectomy Linked to Higher Patient Satisfaction

A study from Hubei Cancer Hospital has found that breast cancer patients undergoing nipple-sparing mastectomy report significantly higher satisfaction with their breast appearance and sexual well-being than those who had skin-sparing mastectomy.

Stem Cell Transplantation Outperforms Leading Multiple Sclerosis Therapies

Autologous haematopoietic stem cell transplantation outperforms alemtuzumab and ocrelizumab in relapse prevention for relapsing MS.

Beyond Glucose: Triglyceride Levels May Worsen Outcomes in Gestational Diabetes

Elevated triglycerides in well-controlled gestational diabetes linked to increased pregnancy risks, suggesting lipid monitoring may be crucial.

Rilzabrutinib Offers Hope for Patients with Refractory Urticaria

The RILECSU phase 2 clinical trial has introduced a potential new option: rilzabrutinib.